➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Medtronic
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Lexaptepid Pegol


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Lexaptepid Pegol?

Lexaptepid Pegol is an investigational drug.

There have been 4 clinical trials for Lexaptepid Pegol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Anemia, Chronic Disease, and Kidney Failure, Chronic. The leading clinical trial sponsors are NOXXON Pharma AG and [disabled in preview].

There is one US patent protecting this investigational drug and seventeen international patents.

Recent Clinical Trials for Lexaptepid Pegol
TitleSponsorPhase
Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis PatientsNOXXON Pharma AGPhase 1/Phase 2
Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With CancerNOXXON Pharma AGPhase 2
Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia ModelNOXXON Pharma AGPhase 1

See all Lexaptepid Pegol clinical trials

Clinical Trial Summary for Lexaptepid Pegol

Top disease conditions for Lexaptepid Pegol
Top clinical trial sponsors for Lexaptepid Pegol

See all Lexaptepid Pegol clinical trials

International Patents for Lexaptepid Pegol

Drugname Country Document Number Estimated Expiration Related US Patent
Lexaptepid Pegol Argentina AR111495 2037-05-01 ⤷  Free Forever Trial
Lexaptepid Pegol Australia AU2018261593 2037-05-01 ⤷  Free Forever Trial
Lexaptepid Pegol Brazil BR112019022648 2037-05-01 ⤷  Free Forever Trial
Lexaptepid Pegol Canada CA3056283 2037-05-01 ⤷  Free Forever Trial
Lexaptepid Pegol Chile CL2019003086 2037-05-01 ⤷  Free Forever Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Dow
Express Scripts
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.